1. Hong Kong Stocks

  2. •

    Distribution services

  3. •

    Medical distributors
China Health Group Ltd

China Health Group Ltd

HHKEX:673
0.27
HKD
+0.00
(-1.85%)
291.61MMarket Cap
China Health Group Ltd
HKEX:673
(Hong Kong Exchange)

Recent

price

0.27

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
HKD
93.94
1.76
0.78
0.35
0.49
0.31
0.07
0.03
0.05
0.06
0.09
0.17
0.21
0.14
0.1
0.06
- -
Revenue per Share
-3.04
-4.66
-0.39
2.12
-0.87
-0.46
-0.22
-0.15
-0.09
-0.05
-0.07
-0.02
-0.02
-0.08
-0.07
-0.11
- -
Basic EPS, GAAP
-0.78
-0.58
-2
-0.24
0.32
-0.14
-0.18
-0.35
-0.09
-0.03
-0.04
-0.02
0.06
-0.04
-0.01
-0.01
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
0.04
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-3.45
-5.23
-4.09
-1.12
-1.79
0.1
0.68
0.27
0.35
0.26
0.19
0.18
0.15
0.15
0.09
-0.01
-0.03
Book Value per Share
-4.5
-5.26
-4.09
-1.79
-1.8
0.09
0.68
0.23
0.32
0.23
0.14
0.14
0.07
0.08
0.04
-0.03
-0.05
Tangible Book Value per Share
29
45
63
66
78
121
340
452
445
506
515
515
515
533
594
609
553
Basic Weighted Avg Shares
2,770
78
49
23
38
38
24
15
24
32
45
88
107
76
60
39
- -
Sales/Revenue/Turnover
-0.9
-21.78
-70.77
-132.91
-95.02
-64.05
-230.67
-495.56
-138.85
-88.21
-53.03
-13.72
-10.71
-15.46
-62.51
-152.69
- -
Operating Margin (%)
5
5
2
4
10
- -
- -
1
1
2
3
4
4
4
5
3
- -
Depreciation Expense
-90
-208
-25
141
-68
-56
-73
-69
-39
-23
-37
-8
-12
-42
-40
-68
- -
Net Income, GAAP
- -
- -
- -
0.21
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-3.24
-265.44
-50.09
607.96
-179.14
-147.86
-308.71
-462.19
-161.86
-71.72
-81.22
-8.81
-11.4
-55.02
-67.06
-174.07
- -
Profit Margin (%)
-64
89
-170
-61
-105
36
162
-1
42
74
51
47
1
15
17
-17
-42
Working Capital
- -
45
- -
- -
- -
- -
- -
- -
- -
- -
2
1
- -
- -
- -
- -
- -
LT Debt
-22
-131
-164
-3
-101
37
180
110
161
132
101
100
85
94
60
- -
-11
Total Equity
- -
- -
- -
130.52
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
-588.17
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
-77.67
-47.72
-28.96
-15.84
-32.26
-8.07
-13.98
-50.69
-58.09
- -
- -
Return on Common Equity (%)

Capital Structure

HKD

•

in mil. unless spec.
Sep'25
Mar'25
Sep'26
ST Debt
6
6
6
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
614
614
614
Market Capitalization
354
118
292

Working Capital

HKD

•

in mil. unless spec.
Sep'25
Mar'25
Sep'26
Total Current Assets
125
115
169
Cash, Cash Equivalents & STI
2
1
63
Accounts Receivable, Net
24
21
21
Inventories
19
14
11
Total Current Liabilities
115
132
212
Payables & Accruals
- -
- -
- -
ST Debt
6
6
6
Deferred Revenue
- -
- -
- -

Growth Rates

HKD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
21.71%
-28.3%
-99.84%
Free Cash Flow
-33.01%
-130.91%
18.86%
Net Income, GAAP
28.74%
57.5%
68.69%
Sales/Revenue/Turnover
9.19%
6.24%
-35.02%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
60
2025
- -
- -
39
2026
- -
- -
- -

Semi-annual Earnings Per Share

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
-0.07
2025
- -
- -
-0.11
2026
- -
- -
- -

Semi-annual Dividends Per Share

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -
Similar Companies
DataMeds AI, Inc. (NASDAQ:MEDS)
Selcuk Ecza Deposu Ticaret ve Sanayi A.S. (BIST:SELEC)
McKesson Corporation (NYSE:MCK)
Ibnsina Pharma (EGX:ISPH)
Cardinal Health, Inc. (NYSE:CAH)
Entero Healthcare Solutions Limited (NSE:ENTERO)
Business
China Health Group Limited (0673.HK) is a Hong Kong-based investment holding company principally engaged in the distribution and services of medical equipment and consumables in the People's Republic of China. The company operates through four main segments: Distribution and Service in Medical Equipment and Consumables, which includes trading of medical equipment, consumables, and pharmaceutical products; Hospital Operation and Management Services, encompassing the management of facilities such as Shuangluan District People's Hospital, Anping Bo'ai Hospital, Luanping County Red Cross Hospital, and Hong Fu Eldercare and Nursing Home; Business Service, involving property investment and factoring services; and Research and Development and Sale of Functional Food. It pursues a hospital investment management model under the Jingming management mode, integrating digital smart healthcare, supply chain services, physician alliances, education and training platforms, and investment financing; key subsidiaries include China Health Group Health Industry (Shenzhen) Co., Ltd., China Health Group International Finance Lease (Shenzhen) Co., Ltd., and China Health Group Ganfu Equity Investment Management (Xiamen) Co., Ltd. The company targets public, private, and regional hospitals across North China, East China, and South China, with operations radiating nationwide from a base in Shenzhen and leveraging Hong Kong's capital markets for mergers, acquisitions, and trusteeships of second-class or above medical institutions. Incorporated in 2001 and headquartered at Unit 801, 8/F, China Insurance Group Building, 141 Des Voeux Road Central, Hong Kong, it was formerly known as China HealthCare Holdings Limited before changing its name in September 2015. Recent developments include the lapse in June 2025 of a major transaction to acquire 100% equity in ProteinT (Tianjin) Diagnostic Co., Ltd., with no material adverse impact on operations; ongoing loan recovery efforts as supplemented in the annual report for the year ended March 31, 2025; and a reported net sales revenue decline of 35.02% alongside total assets decrease of 23.38% in fiscal 2025, reflecting challenges in its healthcare distribution and management activities.